Patent · US Expired

Immunoassays for lamotrigine

US7678551B2 · kind B2 · utility

8Cited by
18References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 20, 2005
Grant dateMar 16, 2010
Priority date
Expiry dateOct 20, 2025

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T436/13
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Generally, the present invention relates to lamotrigine analogs that have substituents at the triazine 3-position and on the benzene 4-position and 5-position. The lamotrigine analogs can include immunogenic moieties that can be used to prepare anti-lamotrigine antibodies, or antigenic moieties that can be used in immunodiagnostic assays for lamotrigine. Also, the lamotrigine analog can include tracer moieties for detecting the presence or amount of the analog during an immunodiagnostic assay. Additionally, the lamotrigine analogs can be used in immunodiagnostic assays to compete with lamotrigine for binding with anti-lamotrigine antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.